STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • November 13th, 2024 • Organogenesis Holdings Inc. • Pharmaceutical preparations • Delaware
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of November 12, 2024, by and between Organogenesis Holdings Inc., a Delaware corporation (the “Company”), and [_______________] (the “Selling Stockholder”).
THIRD AMENDMENT TO CREDIT AGREEMENTCredit Agreement • November 13th, 2024 • Organogenesis Holdings Inc. • Pharmaceutical preparations • New York
This Third Amendment to Credit Agreement (this “Amendment”) dated and effective as of November 12, 2024 (the “Third Amendment Effective Date”) by and among ORGANOGENESIS HOLDINGS INC., a Delaware corporation (the “Borrower”), the several banks and other financial institutions or entities party hereto constituting the Required Lenders (as defined in the Credit Agreement referred to below), and SILICON VALLEY BANK, a division of First-Citizens Bank & Trust Company (“SVB”), as the Administrative Agent (in such capacity, the “Administrative Agent”).
SUBSCRIPTION AGREEMENTSubscription Agreement • November 13th, 2024 • Organogenesis Holdings Inc. • Pharmaceutical preparations • New York
This SUBSCRIPTION AGREEMENT (the “Agreement”) is entered into this 12th day of November, 2024, by and among, Organogenesis Holdings Inc., a Delaware corporation (the “Company”), Avista Healthcare Partners III, L.P., a Delaware limited partnership (“Avista Onshore”) and AHP III Orchestra Holdings, L.P., a Delaware limited partnership (“Avista Holdings” and, together with Avista Onshore, the “Subscribers” and each a “Subscriber”).
